Therefore, we speculate that miR-137 may activate TLR4/NF-κB pathway by targeting KDM4A, thereby inhibiting the osteogenic differentiation of mesenchymal stem cells and worsening osteoporosis. The gene discussed is KDM4A; the disease is osteoporosis.